Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GAIL (India) Ltd
NSE:GAIL
|
IN |
|
Baron Oil PLC
LSE:BOIL
|
UK |
|
C
|
Corebridge Financial Inc
NYSE:CRBG
|
US |
|
T
|
Troax Group AB (publ)
STO:TROAX
|
SE |
|
T
|
Tradia Corp
TSE:9365
|
JP |
Pharma Equity Group A/S
Total Receivables
Pharma Equity Group A/S
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Total Receivables
kr37.2m
|
CAGR 3-Years
619%
|
CAGR 5-Years
227%
|
CAGR 10-Years
51%
|
|
|
Jeudan A/S
CSE:JDAN
|
Total Receivables
kr240.9m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
32%
|
CAGR 10-Years
13%
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Total Receivables
kr1.3m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Total Receivables
kr51.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
25%
|
CAGR 10-Years
32%
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Total Receivables
kr1.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
3%
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Total Receivables
kr919.4k
|
CAGR 3-Years
-8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
See Also
What is Pharma Equity Group A/S's Total Receivables?
Total Receivables
37.2m
DKK
Based on the financial report for Dec 31, 2025, Pharma Equity Group A/S's Total Receivables amounts to 37.2m DKK.
What is Pharma Equity Group A/S's Total Receivables growth rate?
Total Receivables CAGR 10Y
51%
Over the last year, the Total Receivables growth was -16%. The average annual Total Receivables growth rates for Pharma Equity Group A/S have been 619% over the past three years , 227% over the past five years , and 51% over the past ten years .
